Regional fMRI Hypoactivation and Altered Functional Connectivity During Emotion Processing in Nonmedicated Depressed Patients With Bipolar II Disorder
- Nathalie Vizueta,
Ph.D. , - Jeffrey D. Rudie,
Ph.D. , - Jennifer D. Townsend,
B.A. , - Salvatore Torrisi,
M.A. , - Teena D. Moody,
Ph.D. , - Susan Y. Bookheimer,
Ph.D. , and - Lori L. Altshuler,
M.D.
From the Semel Institute for Neuroscience and Human Behavior, the Department of Psychiatry and Biobehavioral Sciences, and the Ahmanson-Lovelace Brain Mapping Center and Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles; and the Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles.
From the Semel Institute for Neuroscience and Human Behavior, the Department of Psychiatry and Biobehavioral Sciences, and the Ahmanson-Lovelace Brain Mapping Center and Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles; and the Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles.
From the Semel Institute for Neuroscience and Human Behavior, the Department of Psychiatry and Biobehavioral Sciences, and the Ahmanson-Lovelace Brain Mapping Center and Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles; and the Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles.
From the Semel Institute for Neuroscience and Human Behavior, the Department of Psychiatry and Biobehavioral Sciences, and the Ahmanson-Lovelace Brain Mapping Center and Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles; and the Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles.
From the Semel Institute for Neuroscience and Human Behavior, the Department of Psychiatry and Biobehavioral Sciences, and the Ahmanson-Lovelace Brain Mapping Center and Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles; and the Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles.
From the Semel Institute for Neuroscience and Human Behavior, the Department of Psychiatry and Biobehavioral Sciences, and the Ahmanson-Lovelace Brain Mapping Center and Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles; and the Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles.
From the Semel Institute for Neuroscience and Human Behavior, the Department of Psychiatry and Biobehavioral Sciences, and the Ahmanson-Lovelace Brain Mapping Center and Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California, Los Angeles; and the Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, Los Angeles.
Supplemental Material
appi.ajp.2012.11030349.ds001.pdf (27 KB)